NIH-funded research R01 grant

Mitochondria's role in insulin release for people with type 2 diabetes

Official title: Novel components of mitochondrial regulation of insulin secretion in type 2 diabetes

Funded at Buck Institute for Research on Aging · NIH-11243481 · Data updated 2026-11-12

This project looks at whether restoring a mitochondrial energy step called succinate dehydrogenase can help insulin-producing beta cells respond to glucose in people with type 2 diabetes.

More Diabetes research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionBuck Institute for Research on Aging
NIH-funded
Lab location1 site (Novato, United States)
Project startJanuary 1, 2024
Project endDecember 31, 2028
Funding year2026
Award (this year)$670,313
NIH project number5R01DK135807-03
Project IDNIH-11243481 on NIH RePORTER

Who could benefit from this research

Could help

Adults with type 2 diabetes or healthy organ donors who can provide pancreatic islets for research would be the most relevant contributors to this work.

Less likely to help

Patients with advanced complications, those not participating in tissue donation programs, or those seeking immediate clinical treatments are unlikely to receive direct benefit from this lab-focused project.

What this research studies

Researchers will work with insulin-producing cells taken from human organ donors to see how mitochondria respond when exposed to glucose. They will use precise bioenergetic and cell-physiology measurements and modify genes with CRISPR or use drugs to change metabolic steps. The team will focus on succinate dehydrogenase and related amplification pathways to find which parts fail in type 2 diabetes. Results could point to targets for treatments that restore normal insulin secretion.

Why it matters

Potential benefit: If successful, this work could identify targets that help restore normal insulin secretion and lead to disease-modifying treatments for type 2 diabetes.

How similar studies have gone: Prior laboratory studies have linked mitochondrial function to insulin secretion, but targeting succinate dehydrogenase in human beta cells is a relatively new and emerging approach.

Where this research is happening

  • Buck Institute for Research on Aging
    Novato, United States
    Active

Researchers

  • Principal investigator: Gerencser, Akos a — Buck Institute for Research on Aging
  • Study coordinator: Gerencser, Akos a

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.